Josh Surman

📣 Exciting news from Route 92: A major milestone powering global expansion, advancing clinical evidence, and fueling continued innovation. #ASCENTtechnique #globalstrokecare Full press release – ow.ly/CjPh50YFfYV

@keysers75483297 @JNIS_BMJ 3.1mm- ahajournals.org/doi/10.1161/SV…

@JNIS_BMJ If only the vessels were large enough to accommodate these too big catheters. Anybody know the size of an average M1?

🧠⚡️ Systematic review of 532 LVO patients shows super large bore aspiration catheters achieve high access (92%) and strong reperfusion (81%) with low complications, but modest first-pass effect (~55%) and reliance on non-randomized data highlight the need for larger prospective trials. Read more here: bit.ly/40WLEpb @MagJablonska @marcriboj

@JNIS_BMJ @MagJablonska Great data to back up what @route92med is achieving on the regular!

#PoweredbyTenzing: In 70% of cases with the novel #Tenzing no guidewire or microcatheter is required to reach the target site. Exclusive to advanced #Route92Medical catheter systems. Want to learn more? ow.ly/FhlF50PZloH #stroke #neurointervention

Excellent case by Dr. Robinson and the team at Mercy Jewish Hospital and Mayfield Brain and Spine. With HiPoint® 88 Reperfusion System and Tenzing®-powered delivery, controlled passive advancement supported efficient clot extraction and confident reperfusion. #poweredbytenzing #ASCENTtechnique

During Brain Awareness Week, we’re reminded just how critical time is when it comes to stroke care. From recognition to reperfusion, every step plays a role in patient outcomes. Speed, control, and consistency aren’t just ideals—they’re necessities. At Route 92, we’re committed to advancing techniques and technologies that support physicians in restoring flow—efficiently and effectively. 🧠 Know the signs. ⏰ Act fast. ❤️ Protect the brain. #BrainAwarenessWeek #StrokeAwareness #MedTech #Neurointervention #Route92 #PatientOutcomes

From access to outcome in 10 minutes. @DCNeurosurgeon Ehsan Dowlati, MD, at @MedStarWHC achieves TICI 3 reperfusion in an M1 occlusion using FC 70. #thepoweroftenzing

HiPoint Reperfusion System is "pushing the boundaries" of stroke thrombectomy treatments (Ajit Puri) #ASCENTtechnique #poweredbytenzing This post is sponsored by Route 92 Medical. neuronewsinternational.com/hipoint-reperf…

Perfection.

MIAMI. INDIANA. Chris Pratt (@prattprattpratt) gets us HYPED for the CFP National Championship tonight at 7:30 PM ET on ESPN and the ESPN App 🔥

Though both Sir Edmund Hillary of New Zealand and Tenzing Norgay reached the summit of Everest together, history has largely spotlighted Hillary. cbsn.ws/4s9MLy2

THE MATCH THAT MATTERS: Vessel-optimized catheters enable consistent, safe delivery, supporting your first-pass success in #stroke patients. Visit route92medical.com/hipoint-reperf…

Join us TODAY for our WebNIR - HiPoint in the Real World: Proven Techniques for the Monopoint Approach 🧠 zurl.co/I3UAr 📅 October 22, 2025 | 🕒 3:00 PM CT Registration is free and open to all! #SVIN #WebNIR #StrokeCare #NeuroIntervention #Thrombectomy

Congratulations to Fairfax Radiological Consultants and Inova Fairfax Hospital on a successful first M1 occlusion case using the #HiPoint 88 Reperfusion System, #Tenzing 8 Delivery Catheter, and the 8F Base Camp Sheath! Thank you for demonstrating safe and effective treatment of an .088" catheter in the M1 with TICI 3 results using the Monopoint Approach! Learn more about HiPoint 88 Reperfusion System: route92medical.com/hipoint-reperf… #MonopointMonday #FirstAndOnly

@route92med Great case!

Dr. Michael Robinson at Mercy Health, Mayfield Brain & Spine performs successful intervention with #TICI3 results at the #M1 using the #HiPoint 88 Reperfusion System, #Tenzing 8 Delivery Catheter, and the 8F Base Camp 2.0 sheath. Thank you to Dr. Robinson and team for demonstrating a great .088" to M1 case using the Monopoint Approach! Learn more about HiPoint 88 Reperfusion System: lnkd.in/eVdSBBwk #MonopointMonday #FirstAndOnly

Before SUMMIT MAX: Can an 0.088” be delivered to the M1 consistently? After SUMMIT MAX: Yes, it can. As the First and Only randomized controlled trial comparing aspiration thrombectomy devices, #SUMMIT_MAX proves it. Dr. Ajit Puri highlights how the #HiPoint Reperfusion System, powered by #Tenzing Delivery, makes predictable 0.088” delivery to the MCA a reality — redefining what’s possible in stroke care. 👉Read the full NeuroNews article: neuronewsinternational.com/interventional… #PoweredByTenzing #FirstAndOnly

#SUMMIT_MAX Study: 96% successful delivery to the M1 and 96% of the time no adjunctive devices required in the top 3 sites from the FIRST multicenter, randomized controlled trial for aspiration thrombectomy, using the super-bore #HiPoint® 88 reperfusion catheter and the #Tenzing 8 Delivery Catheter as part of the #Monopoint® system. More at #ESOC booth #D4.

@route92med Great result!

#MonopointMonday: Successful delivery through an extremely tortuous right ICA Terminus with final #TICI2C results and puncture to first pass in 7 minutes. Dr. Dan Tonetti at Cooper University Healthcare demonstrates single pass success using the #HiPoint 88 Reperfusion System with the #Tenzing 8 Delivery Catheter. Thank you for demonstrating a great case using the Monopoint Approach! Learn more about HiPoint 88 Reperfusion System: route92medical.com/hipoint-reperf…